Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer (COLOPET1)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Naestved Hospital.
Recruitment status was  Active, not recruiting
University of Copenhagen
Rigshospitalet, Denmark
Region Zealand
Information provided by (Responsible Party):
Bodil Elisabeth Engelmann, Naestved Hospital Identifier:
First received: July 6, 2012
Last updated: July 9, 2012
Last verified: July 2012

The investigators are investigating the usefulness of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography (18F-FDG PET/CT) for staging and follow-up of colon cancer. Furthermore, the investigators combine 18F-FDG PET findings with clinical and histopathological features, circulating tumor cell (CTC) analyses, tumor gene expression and measurements of circulating cancer biomarkers sUPAR, TIMP-1 and CEA in order to predict tumor recurrence.

The investigators hypothesis: The combination of functional imaging by 18F-FDG PET/CT and pre-existing and evolving molecular biomarkers will optimize tumor characterization, staging of disease and early detection of recurrence.

Condition Intervention
Colon Cancer
Other: 18F-fluordeoxyglucose positron emission tomography/ computed tomography

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Value of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography and Molecular Tumor Characterisation in Preoperative Staging og Postoperative Control of Colon Cancer

Resource links provided by NLM:

Further study details as provided by Naestved Hospital:

Primary Outcome Measures:
  • time to recurrence

Enrollment: 66
Study Start Date: July 2009
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: 18F-fluordeoxyglucose positron emission tomography/ computed tomography
    18F-fluordeoxyglucose positron emission tomography/ computed tomography for preoperative staging and post-operative follow-up

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • clinical or histological diagnosis of malignant clonic neoplasm (distance of more than 15 cm from anal ring)
  • 18 years of age or older
  • written informed consent

Exclusion Criteria:

  • diabetes
  • known malignant disease other than colon cancer
  • known metastatic disease
  • impairment of renal function
  • allergy to CT contrast agents
  • body weight of more than 150 kg
  • claustrophobia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01636674

Sponsors and Collaborators
Naestved Hospital
University of Copenhagen
Rigshospitalet, Denmark
Region Zealand
Principal Investigator: Bodil E Engelmann, MD Naestved Hospital
  More Information

No publications provided

Responsible Party: Bodil Elisabeth Engelmann, MD, research fellow, Naestved Hospital Identifier: NCT01636674     History of Changes
Other Study ID Numbers: SJ-82
Study First Received: July 6, 2012
Last Updated: July 9, 2012
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics
Denmark: Ministry of Health

Keywords provided by Naestved Hospital:
positron emission tomography
computed tomography
colon cancer

Additional relevant MeSH terms:
Colonic Neoplasms
Colonic Diseases
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Site processed this record on November 20, 2014